Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

BACKGROUND: Before the targeted therapies era, cytotoxic chemotherapy (CCT) was an option for advanced hepatocellular carcinoma (HCC), even with the lack of supporting evidence. Since the last decade, sorafenib has been established as the first-line therapy. Although new agents are being incorporate...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: da Fonseca, Leonardo Gomes, Marta, Guilherme Nader, Braghiroli, Maria Ignez Freitas Melro, Chagas, Aline Lopes, Carrilho, Flair Jose, Hoff, Paulo Marcelo, Sabbaga, Jorge
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6293528/
https://ncbi.nlm.nih.gov/pubmed/30545331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5173-0
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料